For the year ending 2025-12-31, BDSX made $88,499K in revenue. -$35,265K in net income. Net profit margin of -39.85%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 88,499 | 71,323 | ||
| Direct costs and expenses | 16,719 | 15,573 | ||
| Research and development | 12,001 | 9,559 | ||
| Sales, marketing, general and administrative | 87,545 | 80,451 | ||
| Impairment loss on intangible assets | 107 | 238 | ||
| Total operating expenses | 116,372 | 105,821 | ||
| Loss from operations | -27,873 | -34,498 | ||
| Interest expense | 7,716 | 8,258 | ||
| Change in fair value of warrant liability, net | 280 | - | ||
| Loss on extinguishment of liabilities | - | -248 | ||
| Other income , net | 604 | 73 | ||
| Total other expense | -7,392 | -8,433 | ||
| Net loss | -35,265 | -42,931 | ||
| Basic EPS | -4.67 | -0.33 | ||
| Diluted EPS | -4.67 | -0.33 | ||
| Basic Average Shares | 7,551,000 | 129,670,000 | ||
| Diluted Average Shares | 7,551,000 | 129,670,000 | ||
BIODESIX INC (BDSX)
BIODESIX INC (BDSX)